In this study an antifungal protein from Urginea indica bulbs was purified to homogeneity by acid precipitation, Diol 300 Gelfiltration, and C 18 reverse phase HPLC. Its molecular mass was estimated to be 29 kDa and periodic acid-Schiff (PAS) staining showed that identified antifungal molecule is a glycoprotein. The neutralization of antifungal activity after periodate oxidation of 29 kDa glycoprotein suggests that the glycan part of the molecule appears to be involved in antifungal activity. N-terminal amino acid sequence of the purified protein was determined as SQLKAXIXDF. This sequence had no sequence similarity with any antifungal proteins. A polyclonal antiserum was raised against purified protein and used in immunolocalization analysis. Results suggest that it is localized to the cell wall of the bulb. Antifungal tests have demonstrated that U. indica protein exerts a fungistatic effect. It completely inhibits the germination of spores and hyphal growth of Fusarium oxysporum.
The antifungal proteins from plants could either be pathogen-induced proteins or constitutively expressed proteins. Low-molecular mass inhibitory compounds such as phenols, melanins, tannins or phytoalexins along with the pathogen-related proteins inhibit the growth of pathogens [1, 2] . Pathogen-related proteins (PR) are divided into five classes [3] . PR protein classes 2 and 3 contain b-1,3-glucanases and chitinases, respectively, which can hydrolyze fungal cell wall and exhibit strong antifungal activities in vitro [4] [5] [6] [7] . Class 1 PR proteins contain related proteins found in a wide variety of plants with molecular masses of approximately 15 kDa that are induced on infection by tobacco mosaic virus. Class 4 PR proteins include acidic proteins with molecular masses of 13-14.5 kDa that have sequence similarity with wound-induced proteins of potato. The mechanism of action of PR protein classes 1 and 4 remains unknown. Class 5 PR proteins include a number of proteins called thaumatin-like proteins [8] [9] [10] . Several constitutively expressed antifungal proteins include cysteine-rich small proteins [11, 12] , thionins [13] , ribosome inactivating proteins [14] , lipid-transfer proteins [15, 16] , chitin binding proteins [17, 18] , and proteinase inhibitors. These proteins can inhibit a wide variety of phytopathogenic fungi, but display different potencies according to the target microorganism.
Several studies suggest that antimicrobial peptides may have direct antimicrobial activity in vivo, especially the enhanced resistance to microbial pathogens conferred to transgenic plants over expressing thionins [19, 20] , defensin [12] , or LTP [21] . Their constitutive expression and external localization in some plant cells has been described [22] . The antimicrobial peptides contribute to the innate immunity, which refers to the first line defense, limiting infection in the early hours of microbial attack. The concept of innate immunity in plants is becoming relevant after the reappearance of the subject as a central defense mechanism in mammals and insects [23] . In fact unlike phytoalexins, which can have adverse effects in plants, antifungal proteins do not seem to be phytotoxic and attain high level in seeds, tubers, etc. where they are believed to play a role as protectants.
Urginea is one of the extremely interesting polytypic genera with about 100 species and is represented in India by nine species [24, 25] . Urginea indica is also called as Indian squill. Squill bulb has long been used as a source of medicinal product with pharmaceutical and biocidal applications. Bufadienolides of the squill are glycosides used as cardio-tonic agents. The toxicity of the squill bulb is attributed to its scilliroside content [26, 27] . During the course of screening plants for novel antifungal activity, we found that a high molecular weight fraction of an extract from bulbs of U. indica exhibited potent and broad-spectrum antifungal activity against many agronomically important pathogenic fungi.
We describe in this report the isolation and characterization of a 29 kDa antifungal protein from bulbs of U. indica. Periodic acid-Schiff staining showed that it is a glycoprotein. N-terminal sequence analysis of the 29 kDa protein revealed that it does not share any sequence homology with the known antifungal proteins. We have raised neutralizing antibodies against the purified antifungal glycoprotein. The glycoprotein exhibited potent antifungal activity towards commonly encountered agronomically harmful fungi Fusarium oxysporum. In bulb sections of U. indica the protein was predominately localized in the epidermal cell layers.
Materials and methods
The bulbs of U. indica were collected from various forest areas in Karnataka, India. Shim-pack Diol 300 (7.9 mm ID Â 50 cm) gel filtration column and Shim-pack -CLC C 18 reverse-phase column (10 lm 0.46 Â 25 cm) were purchased from Shimadzu, Kyoto, Japan. Molecular mass standard for SDS-PAGE was from MBI Fermentas. FITC-tagged goat anti-rabbit IgG was obtained from Genei, Bangalore, India. All plant pathogens, including F. oxysporum, Rhizoctonia solani, Alternaria tenuissima, Alternaria alternata, Aspergillus niger, Sclerotium rolfsii, and Colletotrichum dematium were isolated from infected seed samples. All reagents were of the highest grade commercially available.
Purification of antifungal protein
Bulbs of U. indica (100 g) were homogenized in 200 ml of 25 mM Tris-HCl buffer, pH 6.8. The extract was centrifuged at 10,000 rpm for 10 min at 4°C and supernatant was subjected to acid precipitation, where pH of the solution was brought down to a pH 2.5 by drop-wise addition of 0.1 N HCl. The acidified solution was placed at 4°C overnight and the precipitate that formed was removed by centrifugation as above. The supernatant obtained was dialyzed extensively against distilled water with a 12 kDa cut-off dialysis membrane. The pH of the dialysate was restored to pH 7 for neutralization. The dialysate was concentrated using BioTron vacuum freeze-dryer before being used for fractionation on a Sephadex G-100 gel filtration column equilibrated with 25 mM Tris-HCl buffer, pH 6.8. Proteins were eluted at a flow rate of 15 ml/ h. The elution profile was monitored at 280 nm using Hitachi U-2000 Spectrophotometer. The antifungal activity was assayed for every third tube before pooling the activity peaks. The pooled active fraction of peak 2 ( Fig. 1A ) was applied to Shim-pack Diol 300 gel filtration column that had been equilibrated with 25 mM Tris-HCl buffer, Fig. 1 . (A) Purification of antifungal protein from U. indica. Dialysed and neutralized acid extract (200 mg) was applied on a Sephadex G100 column (1 Â 100 cm), Column was eluted at a flow rate of 15 ml/h with Tris-HCl buffer, pH 6.8. Every third fraction was assayed for antifungal activity. (B) Fractionation of active fraction from the Sephadex G-100 by Diol-300 HPLC gel filtration column. The arrow indicates the major peak with antifungal activity. (C) The peak marked in (B) was further purified by chromatography with gradient on C 18 RP-HPLC. About 30 mg of protein was applied to a Shim pack CLC-C 18 (25 cm) column equilibrated with 0.1% TFA in water. Column was eluted at a flow rate of 1 ml/min and elution profile was monitored at 280 nm. Inset: Periodic acid-Schiff staining of purified antifungal glycoprotein. pH 6.8. Proteins were eluted from the column at a flow rate of 1 ml/min with Shimadzu HPLC system model LC 10AS. Major peak containing antifungal activity was concentrated and purified further on HPLC Shim pack C 18 reverse phase column equilibrated with 0.1% trifluoroacetic acid (TFA) in water. After a 10 min washing phase, proteins were eluted by a linear gradient of acetonitrile 0-80% in 0.1% TFA at a flow rate of 1 ml/min for 60 min. Fractions were collected and concentrated to dryness using a vacuum concentrator. Protein concentration was determined by Lowry's method and assayed for antifungal activity. A major peak that eluted at 50% acetonitrile showed strong antifungal activity. SDS-PAGE showed that this fraction contained a homogeneous protein with a molecular mass of approximately 29 kDa.
Characterization of antifungal protein
Protein analysis. Protein concentration was determined by Lowry's method, using bovine serum albumin (BSA) as reference standard. Electrophoretic separation was performed following the method of Laemmli [28] , using 12% polyacrylamide gel with a 5% polyacrylamide stacking gel. Electrophoresis was done at 100 V. The resulting gel was stained with silver reagents. The molecular weight of the protein was determined by comparison of its electrophoretic mobility with those of the molecular weight marker proteins.
Analysis of carbohydrate content by total sugar estimation. The presence of sugars bound to the protein was determined by phenol sulfuric acid method of Dubois et al. [29] . Glucose (0-25 lg) was used as reference standard.
Periodic acid-Schiff (PAS) staining for glycoprotein. SDS-PAGE was carried out in slab gels according to the method described in electrophoresis. After electrophoresis the gel was placed in fixative (7.5% acetic acid), rocked gently for 60 min. To oxidize the oligosaccharides the gel was treated with 0.2% periodic acid for 45 min at 4°C. The gel was washed with distilled water and stained with Schiff's reagent in dark at 4°C.
Oxidation of carbohydrate moieties of glycoprotein. In brief, the purified glycoprotein was dissolved in 20 mM phosphate buffer, mixed with an equal amount of 25 mM sodium meta-periodate. The solution was placed in dark at 4°C overnight with shaking at regular intervals. After 24 h the solution was extensively dialyzed against distilled water to remove excess periodate. The protein concentration was determined by Lowry's method before being used for antifungal assays.
Amino acid sequence analysis. The N-terminal amino acid sequence of U. indica 29 kDa antifungal glycoprotein was analyzed by means of automated Edman degradation. Microsequencing was carried out using an Applied Biosystem Procise Edman sequencer. N-terminal sequence homology was analyzed using the BLAST database search.
Assay of antifungal activity. All experiments were conducted under sterile condition. Standard antifungal assays were carried out in 100 Â 15 mm diameter petri dishes, containing 15 ml of potato dextrose agar medium (PDA). For the assay, 0.2 mm diameter wells were made using sterile cork borer. Fungal spores were harvested from actively growing fungal cultures and suspended in sterile distilled water. After adjusting spore concentration to 5 Â 10 5 spores/ml, the spore suspension was spread on agar plates evenly and plates were placed at room temperature for 5 min. The test protein sample was passed through 0.4 lm filter (Millipore) and added to the well in the spore bearing agar plates. Tris buffer (25 mM, pH 6.8) was added on to the control plates. Plates were incubated at 37°C for 72 h in an incubation chamber with near ultraviolet light (NUV) and photographed. Assay was also carried out with different concentrations of protein in order to determine the lowest inhibitory concentration.
Effect of antifungal protein on fungal morphology. To evaluate the effect of purified protein on fungal hyphae, mycelial mats adjacent to the wells were harvested at regular intervals from 0 to 72 h after application of test solution (10 lg of antifungal protein). The samples were squashed and stained with lactophenol cotton blue, before observing under light microscope (Nikon, China) and photography.
Polyclonal antiserum production. Polyclonal antibodies were raised in New Zealand white male rabbit (weighing 4.0 kg) to the purified protein of 29 kDa. Approximately 100 lg protein was emulsified in complete Freund's adjuvant and administered to rabbit by four subcutaneous and intramuscular injections. Subsequent booster injection was administered with antigen emulsified in incomplete Freund's adjuvant. Blood (30 ml) was collected from the rabbit under slight anesthetization, by making a cut in the marginal ear vein. After collection, blood was allowed to clot for 30-40 min at 37°C. Serum was separated from the clot and any remaining insoluble materials were removed by centrifugation at 10,000 rpm for 10 min at 4°C.
Purification of antibodies from antiserum. The immunoglobulin from antiserum was purified by ammonium sulfate precipitation, according to Heide and Schwick [30] , saturated ammonium sulfate was gradually added to 10 ml of rabbit antiserum with constant stirring at 4°C. Suspension was kept on ice for 15 min with occasional stirring followed by centrifugation at 3000 rpm for 30 min at 4°C. Ammonium sulfate (40%, 3 ml) was added to the precipitate and washed thrice (3000 rpm, 30 min at 4°C). Precipitate was reconstituted in a small volume of 0.01 M sodium phosphate buffer, pH 7.2, and it was dialyzed against the same buffer for 24 h with a frequent change of buffer.
Precipitate, which appears in this step, was removed by centrifugation and the supernatant was dialyzed against water before the final dialysis against borate-buffered saline (0.05 M, pH 8.4).
Immunodiffusion. Immunodiffusion was performed by Ouchterlony double diffusion method. Agarose (0.65%) was dissolved in PBS containing sodium azide and poured into petri dishes. Wells were punched in the agarose and peripheral wells were charged with antigen, preimmune serum, BSA, and vehicle (PBS), respectively. The central well contained the antibody (100 lg). Precipitin band was allowed to develop at 37°C for 24-48 h in humidified chamber.
Western blot analysis. The purified protein (10 lg) was resolved on SDS-PAGE and transblotted to a nitrocellulose membrane using capillary transfer. The membrane was washed with TBS-T (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.1% Tween 20) and non-specific sites were blocked with TBS-T containing 3% bovine serum albumin. The blot was treated with primary antibody (antiserum, 1:500 dilution) for 90 min and washed before being treated with the secondary antibody (anti-rabbit IgG, ALP-linked, 1:2000 dilution) for another 90 min. After washing, the membrane was developed with the coloring reagent 4-nitroblue tertrazolium (NBT)/5-bromo-4-chloro-3-indolyl-phosphate 4-toluidine salt (BCIP) at 25°C for 4 min. The reaction was terminated by washing the membrane with distilled water for 10 min.
Immunolocalization. Using purified antibody, immunolocalization studies were carried out in order to localize the protein in U. indica bulb. Thin transverse paraffin sections of bulb were made using microtone and collected on glass slides. The sections were washed with TBS containing 0.2% Tween 20 (TBS-T) for 10 min. Non-specific sites were blocked with TBS-T containing 3% BSA for 1 h. After washing with TBS-T, tissue sections were treated with either pre-immuneserum or primary antibody diluted 100-fold in TBS-T and washed before being treated with secondary antibody (incubation in dark with FITCconjugated goat anti-rabbit IgG using 1000-fold dilution in TBS-T). The slides were washed extensively using TBS-T. All the processing reactions were done at room temperature. For immunofluorescence detection, sections were examined with Leitz Diaplan Fluorescent microscope, Germany, attached to CCD camera.
Results
The Indian squill U. indica is a plant, which is not consumed either by human or by animals due to its toxicity. We were interested in identifying a novel antifungal protein from squill bulb. In the present study we verified for the antifungal activity against some agronomically important plant pathogens. The crude extract of U. indica had potent antifungal activity towards F. oxysporum. Growth of R. solani, A. tenuissima was inhibited to a lesser extent when compared to the inhibition of F. oxysporum. Little or no antifungal activity was seen towards other plant pathogens such as C. dematium, A. niger, and A. alternata.
Purification of antifungal protein from U. indica bulbs
Urginea indica bulb crude extract was subjected to fractionation with acid extraction followed by column chromatographic techniques in order to identify the component responsible for the antifungal activity. The acid extractable component showed antifungal activity towards F. oxysporum and thereby it was subjected to fractionation on a gel filtration column. In Fig. 1A it is shown that the acid extract resolved into two major peaks. Assay of antifungal activity indicated that the activity was associated with peak II. The pooled peak II fraction was further purified using HPLC gel filtration chromatography and of the two peaks that resolved (Fig. 1B) the antifungal activity was associated with the major peak. Upon loading the major peak onto a C18 RP-HPLC column, the protein eluting at 40 min with 50% acetonitrile (Fig. 1C) showed the antifungal activity towards F. oxysporum.
Characterization of purified protein

Carbohydrate analysis
Periodic acid-Schiff staining technique was applied to the detection of glycoprotein. Periodic acid oxidizes the 1,2-glycol groups to aldehyde in polysaccharides, which react with Fuchsin sulfite to form magenta or pink colored bands. The inset in Fig. 1C indicates that the isolated and purified antifungal protein from U. indica is a glycoprotein.
The glycoprotein had a molecular mass of 29 kDa as verified by SDS-PAGE (Fig. 2) . The purified glycoprotein when estimated for the presence of sugar moiety showed the presence of 300 lg of sugar/mg of protein, suggesting that the extent of glycosylation is 30%.
N-terminal sequence analysis
The first 10 N-terminal amino acids of the purified antifungal glycoprotein were determined by automated Edman degradation. By comparing its N-terminal sequence with those available in data banks, we found that it was not identical to any other antifungal proteins published so far. The above sequence; however, exhib- The distance from the center of the well to the growth of the fungi determined the activity of the protein in this work. Moderately active (++), strongly active (+++), very strongly active (++++) denotes distance. About 10 lg of protein/well. Protein (10 lg) in 75 ll of Tris-HCl buffer, pH 6.8, was used for determination of antifungal activity.
ited 60-70% sequence identity with the N-terminal sequence of transcriptional regulator from Pseudomonas syringe and hydroxymethyl pyrimidine kinase from Actinobacillus. The N-terminal sequence of the purified protein also showed 40-50% sequence identity with pathogen-related protein and phage-related protein, respectively (Fig. 3 ).
Antifungal activity of purified protein
The purified protein showed antifungal activity against the agronomically important phytopathogenic fungi such as F. oxysporum, R. solani, A. tenuissima, and S. rolfsii. (Table 1 ). It maximally inhibited the growth of F. oxysporum (Fig. 4A) at the concentration of 10 lg/well. However, the purified protein at a similar concentration had no effect on the growth of C. dematium, A. alternata, and A. niger. In vitro quantitative assays showed that the growth inhibition caused by 29 kDa protein towards F. oxysporum is dose dependent. An estimated value of approximately 10 lg of protein inhibits growth of the above-said fungal pathogen ( data not shown).
Examination by light microscopy showed an inhibition of mycelial growth and sporulation. Morphologically, in protein treated fungus, a dramatic shrinkage of the hyphal tips was observed. Unlike the test sample, the hyphae growing under the influence of sterile Tris-HCl buffer did not show any obvious growth aberrations (Fig. 4B) .
Antifungal activity of oxidized glycoprotein
To ascertain the functional role of carbohydrate moieties of 29 kDa protein, sugar moieties were oxidized with sodium meta-periodate and 10 lg of protein was used for standard antifungal assay. Periodate oxidation of the 29 kDa antifungal glycoprotein showed no antifungal activity (data not shown).
Neutralization of antifungal activity by polyclonal anti-29 kDa antibodies
The 29 kDa antifungal protein from U. indica when used for the production of polyclonal antibodies in rabbit showed to be a potent immunogen. In Fig. 5A is shown a single precipitin band upon reactivity of the antigen with rabbit antiserum. As seen in the figure, no cross-reactivity was obtained with PBS (vehicle) or BSA or pre-immune serum.
Western blot analysis indicates strong detection of 29 kDa antifungal protein in crude extract, acid extract, and purified fractions (Fig. 5B) . When the plate with an equal spore load was charged with the purified fraction of protein, clear antifungal activity was visible but with antigen-antibody complex no such antifungal activity was detected, indicating that the antibodies raised are neutralizing ones (data not shown).
Immunolocalization of the 29 kDa protein
We performed immunofluorescence assay to verify the cellular localization of U. indica antifungal protein.
The polyclonal antibodies raised against purified antifungal protein recognized the protein in the cell wall (Fig. 6) . Typically the peripheral cell layers in the transverse section of the squill bulb stained heavily. The control slides where pre-immune serum was used showed no staining (data not shown).
Discussion
Urginea indica is a common plant with rich medicinal attributes. U. indica is found in sandy soil and also in the hills of lower Himalayas. The extract of U. indica bulb contains glycosides and scillirosides and other toxic scilla glycosides and is generally formulated into rodent bites as dried powder [31] . Despite identifying several active compounds from U. indica bulb, no studies explain the presence of antifungal proteins. In this report we have identified a novel antifungal glycoprotein from U. indica.
Initially when crude extract of U. indica bulb was verified for antifungal activity against the agronomically important pathogens, sensitivity towards inhibition of F. oxysporum was greater when compared to the antifungal activity towards other fungal species. F. oxysporum is a wide-host-range pathogenic fungal species infecting both dicotyledonous and monocotyledonous crops such as mung bean, soybean, azuki bean, cotton, tobacco, potato, maize, and rice.
Further, the acid extractable component of the crude extract showed antifungal activity, suggesting that the protein is of basic nature. The protein was purified to homogeneity and it showed a molecular mass of 29 kDa. A majority of antifungal proteins known to date have a molecular weight exceeding 10 kDa [32, 33] . However, cysteine protease inhibitors from pearl millet seeds and a peptide designated GAPF from Ginkgo biloba leaves are below 10 kDa in molecular weight.
More insight into structure and function of Urginea protein was obtained when the purified protein showed 30% of carbohydrate content with positive PAS, confirming that the identified antifungal protein is glycoprotein. In recent years, the functional significance of the carbohydrate moieties has been increasingly appreciated. Carbohydrates covalently attached to polypeptide chains can confer many functions to the glycoprotein, for example, resistance to proteolytic degradation, the trans- duction of information between cells, and ligand-receptor interactions are a few to mention.
To gain more insight into the structure-function relationship, the purified protein was subjected to sequence analysis and its N-terminal amino acid sequence was determined. Results from the computer search for similarity with other protein sequences showed that the above sequence had no significant similarity with any of the antifungal proteins published so far [34] . Thus, the purified 29 kDa antifungal glycoprotein might be a representative of a novel class of antifungal proteins. These sequences exhibited 70% N-terminal sequence identity with hydroxymethyl pyrimidine kinase from Actinobacillus and 55-60% homology with N-terminal sequence of transcriptional regulator (Tet R) from P. syringe and phage-related protein from Bacillus subtilis. It has to be noted that the above proteins (hydroxymethyl pyrimidine kinase, Tet R, and phage-related proteins) have no antifungal activity towards any of the fungi. In addition, although the purified 29 kDa glycoprotein is not a PR protein, it has 40% sequence identity with the pathogen-related protein from A. thaliana.
The fungal growth inhibitory activity of purified protein differed depending on the fungal species. No effect was observed against C. dematium, A. alternata, and A. niger, partial inhibition was seen for R. solani, A. tenuissima, and S. rolfsii while the growth of F. oxysporum was inhibited significantly. When antifungal activity of U. indica protein is compared with those of other antifungal proteins, it is observed that Urginea protein displays a much broader specificity than others. Antifungal 28 kDa protein isolated from cowpea [35] , 38 kDa Sativin from Pisum sativum [36] , exerts a similar effect on F. oxysporum but not against R. solani. Microscopic observations on morphology of the fungus have shown that growth inhibition by some antifungal proteins is due to swelling and lysis of hyphae [4, 11] . During the course of this work, fungal growth inhibition was routinely checked microscopically to confirm the microspectrophotometric data. A striking difference in the morphology of inhibited hyphae was apparent between fungi harvested from inhibited zone and those with control hyphae.
Studies on the subcellular localization of antifungal protein revealed that antifungal protein accumulated in the cell wall. Most plant fungal pathogens have an extracellular location during the colonization process. Antifungal proteins potentially active in vivo are proposed to be located in peripheral cell layers. In fact, most antimicrobial proteins have this pattern of expression [22] . It is noteworthy that PR proteins generally exist in many isoforms some of which are stored in the vacuole, while others are deposited in the apoplast. Several studies suggest that antimicrobial activity in vivo especially the enhanced resistance to microbial pathogen is conferred to transgenic plants over expressing thionins, defensin [19, 13] or LTP [21] . In addition, their constitutive expression and external localization in some plant cells has been described, suggesting a potential contribution to the innate immunity. In fact unlike phytoalexins, which can have adverse effect, the plant antifungal proteins do not seem to be phototropic and can attain high level in seeds and tubers, where they are believed to play a role as protectants. Our results showed that substantial amount of antifungal protein is located at an external position. Thus, it would be accessible to potential pathogens and is a good candidate to be in the first line defense limiting the infection in the early contact with fungi. We currently have no direct proof for the linkage between the growth inhibition effect shown in vitro and activity of protein in plant but according to its potency it could be a good candidate for transgenic overexpression in plants to evaluate and enhance protection against fungal pathogens.
